10-Q: Ethema Health Reports Soaring Losses Amid Expansion

Ethema Health Corporation reported a significant increase in net loss and a substantial working capital deficiency for Q1 2025, despite revenue growth driven by recent acquisitions.

Summary

• Net loss for the three months ended March 31, 2025, increased by 136.5% to $885,097, compared to $374,203 for the same period in 2024.
• Revenues grew by 170.6% to $3,517,775 for Q1 2025, up from $1,300,100 in Q1 2024, primarily due to the acquisition of Edgewater Recovery Centers, LLC (ERC) and the Boca Raton facility.
• Operating expenses increased by 172.4% to $4,165,177 for Q1 2025, compared to $1,529,175 in Q1 2024, largely driven by acquisition-related costs and staffing for new facilities.
• The company reported an accumulated deficit of $45.3 million, a working capital deficiency of $11.7 million, and total liabilities exceeding total assets by $8.3 million as of March 31, 2025.
• The acquisition of Edgewater Recovery Centers, LLC (ERC) was consummated on January 9, 2025, for $250,000 cash and assumed liabilities, contributing $2,082,082 to Q1 2025 revenues.
• The Boca Raton rehab and detox facility, acquired in June 2024, commenced revenue-generating operations in January 2025, contributing to existing business revenue growth of 10.4%.
• Multiple receivables funding agreements were entered into throughout 2024 and 2025 to support working capital, including several subsequent to the quarter end.
• Disclosure controls and procedures were deemed not effective by the CEO and CFO due to a lack of written policies and procedures for material transactions.

Sentiment

Score: 2

Explanation: The company faces severe financial challenges, including a significant net loss, working capital deficiency, and a going concern warning. While revenue growth is positive, it's largely acquisition-driven and has not translated to profitability. The ineffective disclosure controls further add to the negative sentiment.

Positives

• Total revenues increased significantly by 170.6% to $3,517,775 for Q1 2025, driven by strategic acquisitions.
• The acquisition of Edgewater Recovery Centers, LLC (ERC) added $2,082,082 in revenue during Q1 2025.
• Existing business operations saw a 10.4% revenue increase, reaching $1,435,693, partly due to the Boca Raton facility becoming operational.
• Cash used in operating activities decreased to $73,416 in Q1 2025 from $105,969 in Q1 2024, indicating some improvement in operational cash burn.

Negatives

• Net loss increased by 136.5% to $885,097 for Q1 2025, compared to $374,203 in Q1 2024.
• Operating loss widened by 182.6% to $647,402 for Q1 2025, from $229,075 in Q1 2024.
• The company has an accumulated deficit of $45.3 million as of March 31, 2025.
• A working capital deficiency of $11.7 million was reported as of March 31, 2025.
• Total liabilities exceeded total assets by $8.3 million as of March 31, 2025.
• Interest expense increased by 214.3% to $292,857, largely due to acquisition-related debt and default interest on existing loans.
• Cash provided by financing activities significantly decreased to $26,566 in Q1 2025 from $238,014 in Q1 2024.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring operating losses, accumulated deficit, working capital deficiency, and liabilities exceeding assets.
• Dependence on raising additional capital through equity or debt financing to fund planned expenditures and achieve profitability, with no assurance of success.
• Future equity raises will likely result in significant dilution for existing stockholders.
• New debt financing may impose limitations on operations through covenants or other restrictions.
• The company derives approximately 100% of its revenues from commercial healthcare insurers, making it highly vulnerable to adverse changes in their policies towards substance abuse treatment.
• Disclosure controls and procedures were deemed ineffective by management due to a lack of written policies and procedures to address all material transactions and developments.

Future Outlook

Management plans to continue growing the rehabilitation and detox business organically or through acquisitions. The company estimates requiring approximately $0.5 million in working capital over the next twelve months to develop its Florida and Kentucky operations and explore other treatment center options. It anticipates being dependent on raising additional capital through equity or debt financing to fund its business plan and generate sufficient revenue in excess of costs.

Management Comments

• "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report."
• "Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report."
• "Our management is committed to improving our controls and procedures by, among other matters, continuing to consider and adopt appropriate policies and procedures to address all material transactions and developments impacting our financial statements."
• "We believe that current available resources will not be sufficient to fund our planned expenditures over the next 12 months."

Industry Context

Ethema Health Corporation operates in the addiction treatment sector, a growing but competitive industry. The company's strategy of expanding through acquisitions, such as Edgewater Recovery Centers and the Boca Raton facility, aligns with a trend of consolidation and market share capture in healthcare services. However, its heavy reliance on commercial healthcare insurers for 100% of its revenue exposes it to significant policy and reimbursement risks, a common challenge in the U.S. healthcare system. The company's financial struggles, particularly the going concern doubt, suggest it faces difficulties in integrating acquisitions and achieving profitability in a capital-intensive and highly regulated environment.

Comparison to Industry Standards

• The company's significant revenue growth of 170.6% is notable, but it is primarily acquisition-driven rather than organic, making direct comparison to industry organic growth rates difficult without more detailed breakdowns.
• The substantial net loss and operating loss, coupled with a working capital deficiency of $11.7 million and total liabilities exceeding assets by $8.3 million, indicate severe financial distress, which is significantly below the financial health typically expected of established public companies in the healthcare services sector.
• The disclosure of ineffective internal controls over financial reporting is a red flag, suggesting a lack of robust financial governance compared to industry best practices and regulatory expectations for publicly traded entities.
• The heavy reliance on receivables funding and related-party transactions for liquidity, as well as the explicit 'going concern' warning, are indicators of financial instability that would typically place the company far below industry benchmarks for financial strength and operational independence.

Corporate Governance

Legal Proceedings

• The company is not currently involved in any litigation that is believed to have a material adverse effect on its financial condition or results of operations.

Related Party Transactions

• BH Properties Fund LLC, controlled by CEO Shawn Leon, acquired real property associated with Edgewater Recovery Centers and subsequently entered into 7 lease agreements with ARIA Kentucky LLC (a subsidiary of Ethema) effective January 1, 2025, for a total annual base rental of $1,038,000.
• Eileen Greene, spouse of CEO Shawn Leon, advanced the company $250,000 on July 4, 2024, with an original issue discount of $35,000. Repayments were paused.
• As of March 31, 2025, the company owed Shawn E. Leon $127,596 and Eileen Greene $484,293 in related party payables, which are non-interest bearing and have no fixed repayment terms.
• On July 12, 2024, Shawn Leon converted $1,500,000 of related party payables into 3,000,000,000 common shares.
• On July 12, 2024, Eileen Greene converted $500,000 of related party payables into 1,000,000,000 common shares.
• On September 27, 2024, Shawn Leon converted $6,000 of related party payables into 600,000 Series A Preferred stock shares.
• Liabilities owed to ERC Investments, LLC ($783,679), New Journey, LLC ($46,615), and JDE Properties, LLC ($37,525) from Edgewater were assumed by the company on January 9, 2025. These entities are subsidiaries of BH Properties, controlled by Shawn Leon.
• The company pays monthly rent to ERC Investments, LLC ($76,000), New Journey, LLC ($5,500), and JDE Properties, LLC ($5,000) for properties in Morehead, Kentucky.
• Note payable to ERC Investments, LLC of $34,337 and New Journey Investments, LLC of $48,716, related to funding secured by BH Properties for acquisition obligations.

Stakeholder Impact

• **Shareholders:** Face significant dilution risk from potential future equity raises and have experienced a substantial increase in net loss and accumulated deficit. The 'going concern' warning indicates a high risk to their investment.
• **Employees:** The company's expansion through acquisitions suggests job creation in new facilities, but the overall financial instability and dependence on future financing could pose risks to job security if funding is not secured.
• **Customers (Patients):** Expansion of treatment centers in Florida and Kentucky could increase access to addiction treatment services. However, the company's financial health could impact service continuity if operations are disrupted.
• **Suppliers/Creditors:** Face increased risk due to the company's working capital deficiency, high liabilities, and reliance on receivables funding. Several notes are in default or being renegotiated, indicating potential payment delays.
• **Regulatory Authorities:** The disclosure of ineffective disclosure controls and procedures will likely draw scrutiny from the SEC, potentially leading to further compliance requirements or penalties.

Next Steps

• Continue to grow the rehabilitation and detox business organically or through acquisitions.
• Explore other treatment center options and sources of patients throughout the country.
• Raise additional capital through equity or debt financing to fund planned expenditures and operations.
• Improve disclosure controls and procedures by adopting appropriate policies and procedures to address material transactions.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by a significant net loss, a substantial working capital deficiency of $11.7 million, and total liabilities exceeding assets by $8.3 million. The explicit 'going concern' warning indicates that current resources are insufficient to fund operations for the next 12 months, making the company highly dependent on uncertain future financing. While revenue growth is notable, it is primarily acquisition-driven and has not translated into profitability, with operating losses widening. The ineffective disclosure controls further compound the risk. These factors collectively point to a highly precarious financial position, making the stock a strong sell for seasoned investors.

Keywords

Addiction Treatment, Rehabilitation Services, SEC Filing, 10-Q, Ethema Health Corporation, Financial Results, Acquisition, Going Concern, Working Capital Deficiency, Healthcare Insurers, Related Party Transactions, Receivables Funding